Adam Ang
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The Orthopaedic Surgery team has recently received an international patent for the novel AI for robotic total knee replacement.
The Australian-led project developed these maps, claimed to be the most detailed ever made, to link retinal thinning to various diseases.
Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.
Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.
PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.
The multifunctional biomedical robot can do imaging, sampling, and laser ablation.
Also, Aevice Health from Singapore has obtained new investment for its global expansion.